Caricamento...
Does Natalizumab Induce or Aggravate Psoriasis? A Case Study and Review of the Literature
Psoriasis is a relatively common immune-mediated chronic inflammatory skin disease. It is well known that interferon-beta, a drug used in the management of relapsing-remitting multiple sclerosis, could exacerbate or induce de novo psoriasis. There is limited evidence in the literature based only on...
Salvato in:
| Pubblicato in: | Case Rep Neurol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
S. Karger AG
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6180259/ https://ncbi.nlm.nih.gov/pubmed/30323758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000492891 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|